Corporate governance
Remuneration guidelines
Remuneration to the Chief Executive Officer and other senior executives comprises basic salary and other benefits (relates to car allowance). The company’s senior executives, in addition to the Chief Executive Officer, include an additional five individuals. Decisions on remuneration and benefits to the Chief Executive Officer have been taken by Enzymatica’s Board of Directors. Decisions on remuneration and benefits to other senior executives are prepared by the Chief Executive Officer, who submits a proposal to the Board.
This remuneration policy covers salaries and other terms and conditions for senior executives at Enzymatica AB (publ) “Enzymatica” or the “Company”). Senior executives are those individuals who, along with the CEO, comprise Group Management at Enzymatica.
The purpose of this remuneration policy is to provide guidelines for salaries and other remuneration for the CEO and other senior executives at Enzymatica.
Auditor
The 2022 Annual General Meeting decided to re-elect Deloitte AB to serve as auditor of the parent company for the period until the end of the next Annual General Meeting. In addition to the annual audit, the auditor reviews at least one interim report per year. Authorized auditor Jeanette Roosberg is the principal auditor.
Internal control
Internal control in the company follows the procedures and principles established in the company using various systems, controls and ongoing reporting. The Board of Directors is responsible for compliance with these procedures and principles. Each individual entity in the company is followed up with reporting according to a set schedule and scope. Authorization guidelines and rules of procedure regulate who and how decisions are made regarding length of contract, costs or risk for the company. Signing on behalf of the parent company and subsidiaries, as well as managing cash and cash equivalents, are handled by several people to create good control. Enzymatica does not have an internal audit function because such a function is not justified by the scope and risk exposure of the company.